November 2017 Vol. 9 Issue 111

Abstracts & Commentary

Phytotherapy in Biochemically Recurrent Prostate Cancer

by Michael Traub, ND, DHANP, FABNO  A randomized, controlled trial tests the effects of green tea, resveratrol, broccoli sprouts, and turmeric in men with prostate cancer. Results were unimpressive but the study is not without merit.

Do B Vitamins Cause Lung Cancer?

by Paul Richard Saunders, PhD, ND, DHANP, CCH  Study finds that B vitamins are associated with lung cancer, but only some B vitamins, in some men, in some smokers.

Coriolus versicolor in Advanced Hepatocellular Carcinoma

by Ellen McDonell, ND  Can Coriolus versicolor extract help patients with advanced liver cancers? Results from a randomized controlled trial are not robust, but may lay groundwork for future studies.

OPERA Supplementation for Chemotherapy-Induced Peripheral Neuropathy

by Miranda LaBant, ND  A small prospective study finds a combination of alpha lipoic acid, Boswellia serrata, methylsulfonylmethane, and bromelain improves symptoms in patients with chemotherapy-induced peripheral neuropathy.


Major Research Projects in Naturopathic Oncology

by Natural Medicine Journal Natural Medicine Journal Editor-in-Chief Tina Kaczor, ND, FABNO, recently sat down with Dugald Seely, ND, FABNO, director of the Ottawa Integrative Cancer Centre, to discuss several ongoing studies in integrative oncology.

Intravenous Therapies in Oncology Practice: A conversation with Paul Anderson, NMD

by Natural Medicine Journal There is growing interest among integrative practitioners about the use of intravenous therapies in their practice. In this interview Paul Anderson, NMD, describes the types of therapies being used in oncology and also discusses treatment considerations, contraindications, and research associated with this area of medicine.

Healthcare Perspectives

NMJ Oncology Publisher’s Message

by Karolyn A. Gazella Whether we like it or not, caring for people diagnosed with cancer is no longer a burden that oncologists alone must carry. Because so many people are affected by cancer, their needs spill over into primary care, gynecology, urology, internal medicine and yes, integrative medicine. No matter what your specialty or practice emphasis, chances are very high that you’ve seen people diagnosed with cancer in your clinic. And that’s why, year after year, we tackle this tough topic with a special issue specifically designed with integrative medicine in mind.

Peer-Reviewed Articles

The Human Microbiome in Cancer

by Tina Kaczor, ND, FABNO  Our understanding of the human microbiome continues to mushroom. A review of recent research reveals the influence of dysbiosis on cancer and cancer treatment outcomes.